Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DC/PC3 Vaccine in Prostate Cancer
NCT00345293Phase 2Completed
- Sponsor
- The Rockefeller University
- Start
- Jun 2006
- Primary completion
- Dec 2013
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of DC/PC3 in prostate cancer (PCa), sponsored by The Rockefeller University. Started Jun 2006; status: completed.
02
Drugs
DC/PC3
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00345293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00345293.